At foot of title: NHS National Institute for Health Research.
The clinical effectiveness and cost-effectiveness of centuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the t by M. Hoyle. Published by NIHR Journals Library. Publication and catalogue information, links to buy online and reader comments.